Published in Mol Biol (Mosk) on January 30, 1998
Regulation of riboflavin biosynthesis and transport genes in bacteria by transcriptional and translational attenuation. Nucleic Acids Res (2002) 2.84
Characterization of riboflavin (vitamin B2) transport proteins from Bacillus subtilis and Corynebacterium glutamicum. J Bacteriol (2007) 1.39
Genetic control of biosynthesis and transport of riboflavin and flavin nucleotides and construction of robust biotechnological producers. Microbiol Mol Biol Rev (2011) 1.38
Gene regulation by riboswitches with and without negative feedback loop. Biophys J (2012) 0.77
Finding consensus stable local optimal structures for aligned RNA sequences and its application to discovering riboswitch elements. Int J Bioinform Res Appl (2014) 0.76
A conserved RNA structure element involved in the regulation of bacterial riboflavin synthesis genes. Trends Genet (1999) 2.46
Riboflavin operon of Bacillus subtilis: unusual symmetric arrangement of the regulatory region. Mol Gen Genet (1992) 1.26
Inactivation and mutagenesis on isolated DNA. I. Theory of inactivation of transforming DNA. Mutat Res (1968) 1.14
[DNA nucleotide sequence of the actinomycete plasmid pSB24.2]. Dokl Akad Nauk SSSR (1985) 1.07
The ribR gene encodes a monofunctional riboflavin kinase which is involved in regulation of the Bacillus subtilis riboflavin operon. Microbiology (1999) 1.06
[Riboflavin biosynthetic genes in Bacillus amyloliquefaciens: primary structure, organization and regulation of activity]. Mol Biol (Mosk) (1997) 0.97
Genetic mapping of regulatory mutations of Bacillus subtilis riboflavin operon. Mol Gen Genet (1990) 0.93
[Study of the phenotypic occurrence of ura gene inactivation in Bacillus subtilis]. Genetika (2000) 0.92
Human alpha-L-fucosidases. Clin Chim Acta (1973) 0.90
Inactivation and mutagenesis on isolated DNA. Iv. Possibility of integration of lethal damage into the chromosome of Bacillus subtillis during transformation. Mutat Res (1969) 0.88
Inactivation and mutagenesis on isolated DNA. V. The importance of repairing enzymes for the inactivation of transforming DNA in vitro. Mutat Res (1970) 0.85
Molecular heterozygotes in Bacillus subtilis and their correction. Mol Gen Genet (1971) 0.84
Correction of molecular heterozygotes in the course of transformation. Mol Gen Genet (1968) 0.84
[Ontogenetic switching-over in Bacillus subtilis. I. The characteristics of the mutants conditionally resistant to catabolic repression]. Genetika (1977) 0.83
[Unusual structure of the regulatory region of the riboflavin biosynthesis operon in Bacillus subtilis]. Mol Biol (Mosk) (1990) 0.82
[Operon of riboflavin biosynthesis in Bacillus subtilis. XVI. Localization of the ribC-group markers on the chromosome]. Genetika (1979) 0.82
[Operon of riboflavin biosynthesis in Bacillus subtilis. XVII. A study of the regulatory functions of the intermediate products and their derivatives]. Genetika (1986) 0.81
[Cloning of ribR, an additional regulatory gene of the Bacillus subtilis riboflavin operon]. Genetika (1997) 0.80
[Riboflavin biosynthesis operon of Bacillus subtilis. Effect of genotype on guanosine-5-triphosphate cyclohydrolase synthesis]. Genetika (1979) 0.80
[Genetic mapping of an additional regulatory locus of the riboflavin operon of Bacillus subtilis]. Genetika (1996) 0.80
Study of the operon of riboflavin biosynthesis in Bacillus subtilis. IV. Regulation of the synthesis of riboflavin synthetase. Investigation of riboflavin transport through the cell membrane. Sov Genet (1974) 0.79
Growth of the obligate methylotroph Methylobacillus flagellatum under stationary and nonstationary conditions during continuous cultivation. Biotechnol Bioeng (1992) 0.79
-L-fucosidase and other glycosidases in human placenta, foetus liver and amniotic fluid at various stages of gestation. Clin Chim Acta (1971) 0.79
[Study of the kinetics of the reaction reuniting DNA fragments catalyzed by DNA-ligase. Case of homogeneous molecules]. Mol Biol (Mosk) (1980) 0.78
[Cloning the amidase gene from Rhodococcus rhodochrous M18 and its expression in Escherichia coli]. Genetika (2006) 0.77
[Kinetics of the reactions joining DNA fragments, catalyzed by DNA-ligase. II. Heterogeneous mixture of fragments. Optimization of the reaction conditions]. Mol Biol (Mosk) (1982) 0.77
[Relationship between the secondary structure and the regulatory activity of the leader region of the riboflavin biosynthesis operon in Bacillus subtilis]. Genetika (2008) 0.77
[The characterization of internal promoters in the Bacillus subtilis riboflavin biosynthesis operon]. Genetika (2012) 0.77
[Elimination of introns from the interleukin 1 beta genome by DNA amplification and expression of interleukin 1 beta in Escherichia coli]. Mol Biol (Mosk) (1992) 0.77
[Operon for riboflavin synthesis in Bacillus subtilis. XI. Determination of the type of regulation using a test for dominance of operator-constitutive and regulator-constitutive mutations]. Genetika (1976) 0.77
Main physicochemical features of monofunctional flavokinase from Bacillus subtilis. Biochemistry (Mosc) (2003) 0.76
[Effects of different concentrations of chloramphenicol on RNA synthesis in E. coli]. Biokhimiia (1979) 0.76
[Operon of riboflavin biosynthesis in Bacillus subtilis. VIII. Localization of group ribC markers in relation to the structural gene cluster group]. Genetika (1975) 0.76
[Cloning and expression in Bacillus subtilis of the gene for neutral protease of Bacillus brevis]. Mol Biol (Mosk) (1991) 0.76
[Riboflavin biosynthesis operon of Bacillus subtilis. XIV. Operator-constitutive mutants]. Genetika (1978) 0.75
[Riboflavin biosynthesis operon of Bacillus subtilis. XIII. Genetic and biochemical study of mutants with regard to intermediate stages of biosynthesis]. Genetika (1977) 0.75
[Features of genome expression of phage transposon D3112 of Pseudomonas aeruginosa in Escherichia coli bacteria: dependence of bacterial phenotype on copy number of D3112 genome]. Genetika (1991) 0.75
[Effect of radon vapor baths on the indices of kidney function in hypertension patients]. Vopr Kurortol Fizioter Lech Fiz Kult (1983) 0.75
Inactivation and mutagenesis on isolated DNA. 3. Additivity of action of different agents on transforming DNA. Mutat Res (1968) 0.75
[Risk--benefit relations in radon therapy]. Vopr Kurortol Fizioter Lech Fiz Kult (1983) 0.75
[Experience in using solid-state radon generators in radon laboratories]. Vopr Kurortol Fizioter Lech Fiz Kult (1997) 0.75
[The hygienic problems of radon in enclosed quarters and the possible means for their resolution]. Gig Sanit (1993) 0.75
[An isolation compartment for performing air-radon baths]. Voen Med Zh (1992) 0.75
[Maximum permissible concentrations of radon, thoron, actinon and their daughter products in water and in air]. Gig Sanit (1973) 0.75
[Air-radon procedures]. Vopr Kurortol Fizioter Lech Fiz Kult (1982) 0.75
[Methods of evaluating balneological procedures in animal experiments]. Vopr Kurortol Fizioter Lech Fiz Kult (1983) 0.75
[Mutagenic action of O-methlhydroxylamide on transforming DNA]. Genetika (1983) 0.75
[Radon capsule for therapeutic application]. Vopr Kurortol Fizioter Lech Fiz Kult (2003) 0.75
[Experience in the decontamination of human skin contaminated with polonium]. Gig Sanit (1971) 0.75
[Rehabilitative treatment of patients with ureterolithiasis using pulsed vacuum depression, pulsed low-frequency electric current, and radon therapy]. Vopr Kurortol Fizioter Lech Fiz Kult (2009) 0.75
[Belokurikha health resort: opinion of an outsider]. Vopr Kurortol Fizioter Lech Fiz Kult (2003) 0.75
[Operon of riboflavin biosynthesis in Bacillus subtilis. XV. A study of mutants related to the initial stages of biosynthesis. The origin of the ribityl chain of the riboflavin molecule]. Genetika (1978) 0.75
[Effect of Belokurikha resort water, obtained in biological objects]. Vopr Kurortol Fizioter Lech Fiz Kult (2001) 0.75
[Entrance of substances into the body during balneotherapeutic procedures]. Vopr Kurortol Fizioter Lech Fiz Kult (1985) 0.75
[The combined therapy of patients with chronic nonspecific pyelonephritis using interference currents and and radon procedures]. Vopr Kurortol Fizioter Lech Fiz Kult (2000) 0.75
[Internal application of radon water (alphatherapy)]. Med Radiol (Mosk) (1966) 0.75
Inactivation and mutagenesis on isolated DNA. II. Kinetics of mutagenesis and efficiency of different mutagens. Mutat Res (1968) 0.75
[Rectal suppositories from cacao butter saturated with radon]. Vopr Kurortol Fizioter Lech Fiz Kult (2002) 0.75
[Method of freeze preparation and storage of batches of aqueous radon solutions for baths]. Vopr Kurortol Fizioter Lech Fiz Kult (1981) 0.75
[A self-contained unit for preparing and performing dry-air radon baths]. Vopr Kurortol Fizioter Lech Fiz Kult (1997) 0.75
[The comparative clinico-physiological characteristics of the action of air-carbon dioxide-radon baths in patients with ischemic heart disease]. Vopr Kurortol Fizioter Lech Fiz Kult (1998) 0.75
[A therapeutic alpha-applicator with radon daughters]. Vopr Kurortol Fizioter Lech Fiz Kult (1995) 0.75
Investigation of the operon of riboflavin biosynthesis in Bacillus subtilis. 3. Production and properties of mutants with a complex regulator genotype. Sov Genet (1974) 0.75
[A radon beta applicator]. Vopr Kurortol Fizioter Lech Fiz Kult (1992) 0.75
[Radiation hormesis, radon therapy and radon prevention of disease]. Vopr Kurortol Fizioter Lech Fiz Kult (2002) 0.75
[Construction of a new type of container (bubbler) for storing radium solutions in radon laboratories]. Vopr Kurortol Fizioter Lech Fiz Kult (1979) 0.75
[Mutagenic action of O-methylhydroxylamine on transforming DNA]. Dokl Akad Nauk SSSR (1981) 0.75
[A method of determining the radon content in exhaled air]. Gig Sanit (1967) 0.75
[Operon of riboflavin synthesis in Bacillus subtilis. IX. Preparation and properties of lumiflavin- or lumichrome-resistant mutants]. Genetika (1975) 0.75
[Beta-therapy of long nonhealing postburn wounds and trophic ulcers]. Vopr Kurortol Fizioter Lech Fiz Kult (1974) 0.75
[Mechanisms of the therapeutic and prophylactic effect of radon procedures in light of modern studies in the area of molecular biology]. Vopr Kurortol Fizioter Lech Fiz Kult (2002) 0.75
[The problems of radon therapy: its benefits and risks]. Vopr Kurortol Fizioter Lech Fiz Kult (1998) 0.75
[Rapid method for evaluation of the level of radon and radon derivatives in the air]. Gig Sanit (1993) 0.75
[Results and developmental prospects of radon therapy in the USSR]. Vopr Kurortol Fizioter Lech Fiz Kult (1981) 0.75
[Method of assessing the extent of radiation hazards with simultaneous presence of the daaughter products of radon and thoron in the air]. Gig Sanit (1967) 0.75
[Phenotypic expression of a 100-pair nucleotide deletion in the regulatory region of the Bacillus subtilis riboflavin operon]. Genetika (1997) 0.75
[Analysis of the primary structure of the supplementary regulatory region of the riboflavin operon in Bacillus subtilis]. Genetika (1997) 0.75
[New apparatus for performing radon inhalations and air-radon baths at the Pyatigorsk health resort]. Vopr Kurortol Fizioter Lech Fiz Kult (1980) 0.75
[Mutagenesis by using o-methylhydroxylamine on isolated plasmids]. Dokl Akad Nauk SSSR (1983) 0.75
[Radiological and technical balneological conditions for exploiting natural radon waters]. Vopr Kurortol Fizioter Lech Fiz Kult (1979) 0.75
[Radon baths in the complex treatment of burn disease]. Vopr Kurortol Fizioter Lech Fiz Kult (1973) 0.75
[Mechanisms of the biological and therapeutic effect of radon procedures]. Vopr Kurortol Fizioter Lech Fiz Kult (1972) 0.75
[The presence in the skin of a barrier for the inert gas radon]. Vopr Kurortol Fizioter Lech Fiz Kult (1994) 0.75
[Allowable concentration of radionuclide in mineral water, therapeutic mud and clay]. Vopr Kurortol Fizioter Lech Fiz Kult (2001) 0.75
[Beta therapy of postburn keloid scars]. Klin Khir (1979) 0.75
[Impact of volumetric activity of radon on the concentration of air ions and on the power of electric field]. Gig Sanit (2003) 0.75